Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 4/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67836 | 0.96 | APOBEC3A (0.50) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL14736244 | 0.79 | APOBEC3A (0.44) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL5433650 | 0.78 | LMNA (0.42) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| Methylamine SCHEMBL6091448 | 0.76 | PKM (0.57) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL14736538 | 0.75 | APOBEC3A (0.60) | APOBEC3AAPOBEC3GTSHRCTDSP1MEN1 | |
| SCHEMBL3054669 | 0.75 | APOBEC3A (0.42) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL5726080 | 0.75 | BCAT2 (0.44) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL21879818 | 0.75 | APOBEC3A (0.42) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL20164040 | 0.75 | PKM (0.47) | APOBEC3AAPOBEC3GPKMGAATSHR | |
| SCHEMBL23716719 | 0.73 | APOBEC3A (0.41) | APOBEC3AAPOBEC3GPKMGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539707-A4 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | BIODIEM LTD (AU) | 2007-05-30 | — | — | EP | disclosed |
| US-20060135587-A1 | Method and compounds for promoting healing and reducing inflammation | BIODIEM, LTD. (AU) | 2006-06-22 | — | — | US | disclosed |
| EP-1539707-A1 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | Biodiem Ltd. (AU) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004013108-A1 | METHOD AND COMPOUNDS FOR PROMOTING HEALING AND REDUCING INFLAMMATION | BIODIEM LIMITED (AU) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135587-A1 | Method and compounds for promoting healing and reducing inflammation | IL1B, MIF, ALKBH5 | APOBEC3A 3574/4885APOBEC3G 3236/4885PKM 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.